AzTrials
AzTrials

Energy BalanceNCT02258399

Exercise in the Fasted State, Glucose Metabolism and Energy Balance

A study testing Exercise and Breakfast in people with Energy Balance and Blood Glucose, run by University of Bath at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The ability to control our blood glucose (sugar) concentrations after a meal is a strong predictor of the risk of disease. Our bodies respond to glucose ingestion by reducing the amount of glucose from the liver entering the bloodstream. Read more about this study

Who is it for?
Ages 18 to 49 years, men onlyHealthy volunteers can take part
Conditions the study is for
Energy Balance, Blood Glucose
What is being tested?
Exercise and Breakfast
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
1 siteUnited Kingdom
Study dates
May 2015to Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 49 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Males.
  • Aged 18-49.
  • Individuals free from known cardiovascular, metabolic or joint disease as determined by standard health questionnaire.
  • Habitual regularly participating in exercise (minimum of 3 sessions per week on average)
  • Non-smoker

Who cannot join

  • Known or suspected food intolerances, allergies or hypersensitivity.
  • Any bleeding disorder or taking medication which impacts blood coagulation.
  • Known tendency towards keloid scarring.
  • Known sensitivity or allergy to any local anaesthetic medicines.
  • Any reported use of substances which may pose undue personal risk to participants or introduce bias into the experiment.
  • Any other condition or behaviour deemed either to pose undue personal risk to participants or introduce bias into the experiment.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Department for Health, University of Bath

    Bath, BA2 7AY

Other trials in United Kingdom

About this study

The ability to control our blood glucose (sugar) concentrations after a meal is a strong predictor of the risk of disease. Our bodies respond to glucose ingestion by reducing the amount of glucose from the liver entering the bloodstream. At the same time muscle increases the amount of glucose it take up from the bloodstream. This ensures that our blood glucose levels do not get too high. The investigators want to understand what happens to these processes following exercise after breakfast and after an overnight fast. In addition, the investigators also want to understand whether exercising with or without breakfast influences our appetite, food intake and activity levels later in the day.

Being tested
Exercise, Breakfast

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ExerciseBehavioural

    Moderate intensity exercise

  • BreakfastDietary supplement

    Breakfast consumption

Study groups in NCT02258399
Study groupRoleWhat they receive
Breakfast RestActive comparatorNot described
Receives: Dietary Supplement: Breakfast
Breakfast ExerciseActive comparatorNot described
Receives: Behavioral: Exercise; Dietary Supplement: Breakfast
Fasted ExerciseExperimentalNot described
Receives: Behavioral: Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Exogenous glucose appearance rate

    Exogenous glucose appearance rates following an oral glucose tolerance test (total appearance over 120 minutes).

    Measured: 120 minutes

  2. Energy balance

    Energy balance (intake minus expenditure) over 24 h from the beginning of the trial

    Measured: 24 hours

Secondary outcomes (5)
  1. Endogenous glucose appearance rates

    Endogenous glucose appearance rates following an oral glucose tolerance test (total appearance over 120 minutes).

    Measured: 120 minutes

  2. Glucose clearance rates

    Glucose clearance rates following an oral glucose tolerance test (total clearance over 120 minutes).

    Measured: 120 minutes

  3. Energy intake

    Weighted energy intake over 24 hours from the beginning of the trial.

    Measured: 24 h

  4. Energy expenditure

    Energy expenditure, derived from indirect calorimetry, acccelerometry and heart rate monitoring.

    Measured: 24 h

  5. Exogenous glucose appearance rates

    Exogenous glucose appearance rates following an oral glucose tolerance test (total appearance over 120 minutes).

    Measured: 120 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Oct 2014 (estimated)
  2. Study startMay 2015
  3. Primary completionJun 2016
  4. Study completionDec 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02258399
Sponsor's protocol ID
RE-FH1109
Status last verified
Mar 2018
First submitted
2 Oct 2014
Last updated
2 Apr 2018
Results posted
No

Publications

  • Gonzalez JT. Paradoxical second-meal phenomenon in the acute postexercise period. Nutrition. 2014 Sep;30(9):961-7. doi: 10.1016/j.nut.2013.12.001. Epub 2013 Dec 14.

    PubMed 24986552
  • Gonzalez JT, Veasey RC, Rumbold PL, Stevenson EJ. Breakfast and exercise contingently affect postprandial metabolism and energy balance in physically active males. Br J Nutr. 2013 Aug;110(4):721-32. doi: 10.1017/S0007114512005582. Epub 2013 Jan 29.

    PubMed 23340006
  • Allaf M, Elghazaly H, Mohamed OG, Fareen MFK, Zaman S, Salmasi AM, Tsilidis K, Dehghan A. Intermittent fasting for the prevention of cardiovascular disease. Cochrane Database Syst Rev. 2021 Jan 29;1(1):CD013496. doi: 10.1002/14651858.CD013496.pub2.

    PubMed 33512717
  • Edinburgh RM, Hengist A, Smith HA, Travers RL, Betts JA, Thompson D, Walhin JP, Wallis GA, Hamilton DL, Stevenson EJ, Tipton KD, Gonzalez JT. Skipping Breakfast Before Exercise Creates a More Negative 24-hour Energy Balance: A Randomized Controlled Trial in Healthy Physically Active Young Men. J Nutr. 2019 Aug 1;149(8):1326-1334. doi: 10.1093/jn/nxz018.

    PubMed 31321428

Questions about this trial

What is this clinical trial studying?

A study testing Exercise and Breakfast in people with Energy Balance and Blood Glucose, run by University of Bath at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Apr 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Exogenous glucose appearance rate (time frame: 120 minutes). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02258399, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in